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Abstract:  
 
Background: Hippocampal volume (HV) reduction is well documented in schizophrenia. 
However, it is still unclear whether this change is a pre-existing vulnerability factor, a 
sign of disease progression, a consequence of environmental factors, such as drug use, 
antipsychotic medication, or malnutrition. The timing of HV changes is not well 
established, but a lack of macrostructural hippocampal brain abnormalities before 
disease onset would rather support a neuroprogressive illness model.  
Aim: To investigate the timing of HV changes in emerging psychosis.  
Methods: A cross-sectional MRI study of manually traced HVs in 37 individuals with an 
At Risk Mental State (ARMS) for Psychosis, 23 individuals with First Episode Psychosis 
(FEP), and 22 Healthy Controls (HC) was performed. We compared left and right HVs 
corrected for whole brain volume across groups using analysis of covariance (ANCOVA) 
with gender as a covariate. 16 of 37 ARMS individuals developed a psychotic disorder 
during follow up (ARMS-T). The mean duration of follow up in ARMS was 25.1 months.  
Results: The overall ANCOVA model comparing left HVs across FEP, ARMS and HC 
indicated a significant general group effect (p < .05) with largest volumes in ARMS and 
smallest in FEP. ARMS-T subjects had significantly larger left HVs compared to FE but 
no HV differences compared to HC (p<0.05). Over all groups, we found an asymmetry 
between the left and right mean HVs and a strong effect of sex.  
Discussion: The present study suggests that macrostructural hippocampal abnormalities 
probably occur in the context of the first psychotic breakdown. 
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1. INTRODUCTION  
Structural brain abnormalities in schizophrenia have been detected in post mortem 
studies and in vivo brain imaging studies (Wolf et al, 2008; Kubicki et al, 2007; Whitford 
et al, 2007; Laywer et al, 2006; Bogerts et al, 1990a,b; Witthaus et al, 2008). However, 
the extent to which these findings are related to vulnerability for schizophrenia, as 
opposed to the disease progression, is less certain. The hippocampus as a key region of 
interest has been investigated in numerous studies at different stages of the disease 
(Lopez-Garcia et al, 2006; Nelson et al, 1998; Phillips et al, 2002; Steen et al, 2006; 
Velakoulis et al, 2006) and is among the most robust brain abnormalities found in 
schizophrenia (Seidmann et al, 2003; Knable et al, 2004). The hippocampus is of 
particular interest as it is highly interconnected with other brain regions, including the 
frontal lobe that has also been proposed to be important for schizophrenia (Honea et al, 
2005; Hurlemann et al, 2008; Shenton et al, 2001). A meta-analysis found hippocampal 
volume (HV) reductions of about 4% in chronic schizophrenia (Nelson et al, 1998) and of 
about 2.7% in first-episode schizophrenia (Steen et al, 2006) compared to healthy 
controls (HC). It seems that HV reductions in first-episode psychosis (FEP) are less 
extensive than in chronic populations (Bogerts et al, 1990; Hirayasu et al, 1998; Lawrie 
et al, 1999; Steen et al, 2006; Velakoulis et al, 2006).  
Using voxel-based morphometry (VBM) in ARMS individuals a range of gray (Borgwardt 
et al, 2007a, b; Meisenzahl et al, 2008; Pantelis et al, 2003) and white (Witthaus H et al, 
2008) matter abnormalities across several brain regions could be identified, including 
temporal lobe encompassing hippocampal structures. In our own VBM study (Borgwardt 
et al. 2007 a, b) the left parahippocampus and hippocampus in ARMS was smaller 
compared to controls (at a liberal significance threshold). Within the ARMS group, 
subjects with later transition to psychosis (ARMS-T) showed more gray matter volume 
reduction in the parahippocampal gyrus compared to ARMS without later transition 
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(ARMS-NT). The findings are in accordance with longitudinal follow up data from the 
Melbourne group suggesting that those ARMS individuals who progress towards a 
psychotic illness have left medial temporal structural changes (Pantelis et al, 2003). 
A recent study using manual tracing of the hippocampus across different stages of 
psychotic disorders from ARMS to FEP to chronic schizophrenia did not find 
macrostructural hippocampus abnormalities prior to the first psychotic breakdown 
(Velakoulis et al, 2006). The latter study found that patients with chronic schizophrenia 
compared to HC had smaller hippocampi bilaterally, and FEP with schizophrenia had 
only left-sided HV deficits, whereas those with schizophreniform, affective, or other 
psychoses, as well as ARMS individuals independent of later transition status were not 
different from HC. This study was in accordance with earlier studies that showed left 
hippocampal volume reduction in first-episode psychosis (Velakoulis et al, 1999), but not 
in the baseline MRIs of ARMS individuals who later developed a FEP (Phillips et al, 
2002). Interestingly, the latter small study found that left HVs of ARMS subjects who 
later developed a psychotic disorder were larger than ARMS subjects who did not (but 
were not significantly different compared to the healthy comparison group). In summary, 
these VBM and ROI studies suggest that HVs are differentially affected depending on 
stage and type of psychosis.  
The aim of our study was to further explore the timing of hippocampal volume changes 
in emerging psychosis. Based on our own work (Borgwardt et al. 2007a, b, 2008) and 
previous structural neuroimaging studies (Pantelis et al, 2003; Phillips et al. 2002; 
Velakoulis et al  2006) we hypothesized that HVs of FEP patients are smaller compared 
to individuals with an ARMS, whereas ARMS subjects show smaller HVs compared to 
HC. Furthermore, we hypothesized that HVs of ARMS individuals with later transition to 
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psychosis are smaller compared to ARMS individuals without later transition to 
psychosis, as well as compared to HC.  
 
2. MATERIALS AND METHODS  
2.1 Study design  
This imaging study was embedded in a naturalistic, prospective study on the prediction 
of transition to psychosis in individuals with an ARMS, the Basel Early-detection-of-
Psychosis (FePsy) study. A more detailed description of the overall study design can be 
found elsewhere (Riecher-Rössler et al, 2007). The institutional ethics committee of the 
University of Basel approved all aspects of the study and written informed consent was 
obtained from each participant.  
2.2 Participants  
Subjects were recruited from a service area covering 200.000 inhabitants in and around 
Basel, Switzerland, in the framework of the FePsy project (Früherkennung von 
Psychosen), a multi-domain study on the early detection of psychosis. For screening 
purposes, we used the Basel Screening Instrument for Psychosis, BSIP (Riecher-
Rössler et al, 2008), a 46-item checklist based on variables which have been shown to 
be risk factors or early symptoms of psychosis (Riecher-Rössler et al, 2006; Riecher-
Rössler et al, 2007, Riecher-Rössler et al, 2009) such as DSM-III-R–‘prodromal’ 
symptoms, social decline, drug abuse, previous psychiatric disorders or genetic liability 
for psychosis. The severity of (pre-)psychotic phenomena was assessed with the Brief 
Psychiatric Rating Scale (BPRS), which was used in combination with the BSIP. The 
BSIP was constructed as a screening checklist to identify those at risk and is followed by 
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a more extensive early detection interview in a next step. To assess the IQ we used the 
MWT (Lehrl, 1991), an established measure in German-speaking subjects. Experienced 
psychiatrists who underwent regular training conducted all assessments.  
2.3 Inclusion criteria  
 
2.3.1 ARMS group  
The ARMS group was defined using criteria corresponding to the PACE criteria (Yung et 
al, 1998, McGorry at al, 2002) employed also in previous MRI studies of subjects with an 
ARMS (Borgwardt et al, 2006, 2007b; Garner et al, 2005; Pantelis et al, 2003; Phillips et 
al, 2002; Velakoulis et al, 2006). Inclusion thus required one or more of the following: a) 
“Attenuated” psychotic symptoms, b) brief limited intermittent psychotic symptoms 
(BLIPS), or c): a first degree relative with a psychotic disorder plus at least two indicators 
of a clinical change, such as a marked decline in social or occupational functioning. 
Inclusion because of “attenuated” psychotic symptoms required scores of 2 or 3 on the 
hallucination item, 3 or 4 on the unusual thought content or suspiciousness items of the 
BPRS for at least several times a week and persisting for more than 1 week. Inclusion 
because of BLIPS required scores of 4 or above on the hallucination item, or 5 or above 
on the unusual thought content, suspiciousness or conceptual disorganization items of 
the BPRS, with each symptom lasting less than 1 week before resolving spontaneously.   
 
2.3.2 FEP group  
Assignment to the FEP group was based on the transition criteria for a psychotic 
episode described by Yung et al (1998) which are shown in table 1. 
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Table 1 here 
 
2.3.3 HC group  
Healthy controls were recruited from the same geographical area as the other groups 
through local advertisements. These individuals had no current psychiatric disorder, no 
history of psychiatric illness, head trauma, neurological illness, serious medical or 
surgical illness, substance dependency (except for cannabis and nicotine), and no family 
history of any psychiatric disorder as assessed by an experienced psychiatrist in a 
detailed clinical interview.  
 
2.4 Exclusion Criteria  
Exclusion criteria are age below 18 years, insufficient knowledge of German, IQ <70, 
previous psychotic episode treated with major tranquillizers for more than 3 weeks 
(lifetime), a clearly diagnosed brain disease or substance dependency (except for 
cannabis dependency), or psychotic symptoms within a clearly diagnosed depressive or 
borderline personality disorder.  
The latter two exclusion criteria are different to the Melbourne ultra-high risk and first 
episode psychosis criteria that do not exclude subjects with a ‘major depression with 
psychotic features’, or Borderline Personality Disorder with psychotic symptoms. We 
decided to exclude those subjects if the primary diagnosis of major depression or 
Borderline personality disorder was present prior to the ARMS to focus on a more 
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narrow at risk sample for schizophrenia. 
 
2.5 Clinical follow-up and transition to psychosis  
 All subjects were followed-up regularly and were offered supportive counselling and 
clinical management. During the first year of follow-up, ARMS individuals were assessed 
monthly. During the second and third year, all individuals were assessed at least 
3monthly and thereafter once a year until transition to frank psychosis or until end of Mai 
2007. Transition to psychosis was monitored using criteria described by Yung et al 
(1998), see table 1.  The diagnosis was determined by a diagnostic interview using 
DSM-IV/ICD-10 research criteria at the time of conversion to frank psychosis, then also 
assessed at least one year post transition using Operational Criteria (OPCRIT) 
(McGuffin et al, 1991).  
2.6 Structural MRI  
2.6.1 Image Acquisition  
Subjects were scanned using a SIEMENS (Erlangen, Germany) MAGNETOM VISION 
1.5T scanner at the University Hospital Basel. Head movement was minimised by foam 
padding and velcro straps across the fore-head and chin. A three-dimensional volumetric 
spoiled gradient recalled echo sequence generated 176 contiguous, 1mm thick sagittal 
slices. Imaging parameters were: time-to-echo, 4msec; time-to-repetition, 9.7msec; flip 
angle, 12; matrix size, 200x256; field of view, 25.6x25.6 cm matrix; voxel dimensions, 
1.28x1x1 mm.  
2.6.2 Manual segmentation of hippocampus volume  
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Significant clusters were anatomically localised using the atlases of Duvernoy (1998) 
and Talairach and Tournoux (1988, 1993). The regions of interest (ROI) were manually 
traced by a single tracer (EB) with a mouse-driven cursor using the interactive public 
domain software program AMIRA, which displays all three planes simultaneously 
(Kappos et al, 2006). The boundaries of the hippocampus were identified including the 
subiculum, cornu ammonis (hippocampus proper), and the dentate gyrus. The amygdala 
was excluded. The regions of interest were defined on the coronal and sagittal slices, 
and finally checked on the coronal plane again. Anterior segmentation was achieved by 
tracing on sagittal slices. The hippocampal volume was traced generally following the 
protocol of Jack et al (1989):  
1. Medial: the border between the subiculum and the parahippocampal gyrus  
2. Lateral: the temporal horn of the lateral ventricle  
3. Inferior: the gray/white matter junction between the subiculum and the white matter in 
the parahippocampal gyrus  
4. Superior: the fimbria was included as the superomedial border of the hippocampus, 
superolateral gray matter, which was clearly the tail of the caudate, was excluded  
5. Posterior, the section where the crura of the fornix are seen in full profile  
6. Anterior: the level at which the uncal recess of the temporal horn, or the alveus is 
visible in the most anterior slice  
The intra-rater reliability ranged from κ=0.962 (left side) to κ=0.97 (right side) using 
manual segmentation in ten consecutive cases that were measured twice within three 
weeks. A inter-rater reliability could not be calculated as there was only one tracer. 
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However, previous studies using the same software on data sets comprising over 1000 
MRI scans showed a very high inter-rater reliability (Kappos et al, 2006). The researcher 
who traced the hippocampus was blind to the group at any time of the study. Once the 
hippocampus has been traced, hippocampal volumes (in mm3) were calculated by 
computing the number of voxels from each traced image. The average number of traced 
slices was 26 (SD 4.1 left, 4.4 right) on both sides. Raw volumes were normalized using 
the following formula for volume correction: Normalized corrected hippocampus volume 
(CV) = Measured volume (MV) – gradient (measured intracranial volume, ICV – mean 
intracranial volume of the control group, ICV), (Free et al, 1995).  
2.6.3 Image Processing for Whole Brain Volumes  
The fully automated software SIENAX (Structural Image Evaluation, using 
Normalisation, of Atrophy in a single-time-point estimation) was used for estimation of 
the whole brain volumes from a single image, normalised for skull size (Smith et al, 
2007). The method has been described elsewhere in detail (www.fmrib.ox.ac.uk/fsl). 
Briefly, the software first strips non-brain tissue, and then uses the brain and skull 
images to estimate the scaling between the subject's image and standard space. It then 
runs tissue segmentation to estimate the volume of brain tissue, and multiplies this by 
the estimated scaling factor, to reduce head-size-related variability between subjects 
(Smith et al, 2002).  
2.7 Statistical analysis  
Statistical analyses were performed with the Statistical Package for the Social Sciences, 
version 15 (SPSS 15.0). Two sets of analysis were performed to test our hypothesis: 
Analysis 1: ARMS, FEP and HC; Analysis 2: Comparison of ARMS-T, ARMS-NT, FEP 
and HC. Within each analysis, patient groups were compared with the control group. 
Hippocampal Abnormalities 
 
11
Demographic data were compared using Chi-square test and Fisher’s exact test for 
categorical variables; Student’s t-tests for psychopathology scores (interval-scaled or 
continuous variables). Left and right HVs corrected for whole brain volumes were 
analyzed using one-way analyses of co-variance (ANCOVA) with sex as a covariate. All 
pair wise mean comparisons used post hoc contrasts to compare patients groups with 
controls, adjusting for sex. Bonferroni adjustment for multiple testing was applied. 
Results of statistical tests are given as mean ± standard deviation (SD). The level of 
statistical significance was set to p<0.05, a trend was considered p<0.1. Unadjusted 
alpha value must not exceed a value of 0.017 in order to reach significance of p=0.05.  
 
3. RESULTS  
3.1 Sample characteristics  
70,3% of ARMS individuals belonged to the prepsychotic group, whereas 18.8% 
belonged to the genetic risk group, and 10.9% had BLIPS in the past. Within the 
prepsychotic group, 20.1% also had a genetic risk. ARMS, FEP and HC did not differ 
significantly with respect to age (χ2=7.7, df=4, p=1.00), sex (χ2 = 1.5, df=2, p=.468) and 
handedness (χ2=3.1, df=2, p=.208). Educational level was significantly higher in HC 
(χ2=14.0, df=4, p=0.007). Antipsychotic medication was more common in FEP compared 
to ARMS (Fisher’s exact test with p=0.022) (table 2). 
 
TABLE 2 ABOUT HERE 
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The mean duration of follow up of the 37 ARMS individuals was 25.1 months (ARMS-T 
12.3 months, ARMS-NT 33.1 months). Sixteen of 37 ARMS individuals (43%) made a 
transition to psychosis. Ten of the transitions occurred during the first year of follow up, 
five in the second year and one in the following years. At intake into the FePsy project, 
subjects who consequently made the transition to psychosis (ARMS-T) did not differ 
from ARMS-NT in age (t=1.46, df=35, P=0.155), sex (Fisher’s exact test p=0.500), 
handedness (Fisher's exact test p=0.287), education (Χ2=2.0, df=3, P=0.580), mean 
BPRS global score (t=1.63, df=35, P=0.113; Mean SANS: t=1.66, df=35, P=0.106) and 
exposure to antipsychotic medications (Fisher’s exact test p=1.00) (table 3).  
 
TABLE 3 ABOUT HERE 
 
3.2 Whole brain volumes, sex and age  
Whole brain volume corrected for age (F=0.3, df=2, P=0.708) did not differ across 
groups. However, women had smaller whole brain volumes in each group (HC: t=-4.025, 
df=20, p <0.010; ARMS: t=-4.445, df=35, p <0.010; FEP: t= -2.031, df=21, p=0.055). Sex 
was therefore included as a covariate in all subsequent ANCOVAs.  
 
3.3 Hippocampal volumes  
Over all diagnostic groups, we found a significant asymmetry between the left and right 
mean HVs (t =-14.548, df=81, p<.01) and a significant effect of sex (left t=4.4, df=80, 
p<.001; right t=3.5, df=80, p=.001). Therefore, all HV group comparisons were analysed 
for each side separately corrected for whole brain volume and with sex as a covariate. 
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Analysis 1 (comparison of ARMS total, FEP and HC) revealed a significant group effect 
for the adjusted left HVs (F2,78=3.5; P=.035). The adjusted right HV did not differ 
(F2,78=0.5, P=.624). The respective power found in these comparisons was 1-β=0.572 for 
the left, and 1-β= 0.120 for the right side. Mean left HVs revealed a 6.9% volume 
reduction in FEP (2993mm3) compared to ARMS (3155mm3) using the Welch two 
sample t-test (t=2.032; df=52.34; P=0.047), however probably as a consequence of the 
relatively small sample size and insufficient power, significance was lost (P=0.14) after 
controlling for multiple comparison using Bonferroni adjustment. The right mean HV did 
not differ between the FEP and ARMS (t=0.861, df=58, p≈1.00). Mean left HV in FEP 
was 4.5% smaller compared to HC without reaching level of significance (t=-1.191, 
df=41.063, p=0.241). The right hippocampus did not differ between these groups (t=-
0.149, df=78, p=0.882). Neither left nor right hippocampal volumes of the ARMS group 
did differ from HC (Welch Two Sample t-test, left: + 2.4%, t=1.037, df=56.424, p=.304; 
right: t=0.35, df=57, p=.727).  
Analysis 2 (comparison of ARMS-T, ARMS-NT, FEP and HC) revealed a trend for group 
effects for the adjusted left HVs (F=2.4, df=3,77, p=0.074, sex effect: F=17.7, df=1,77, 
p<0.001), whereas no significant difference was found for the right mean HV (F=0.3, 
df=3,77, p=.815, sex effect: F=11.1, df=1.77, p<0.01). Interestingly, the power on the left 
side was moderate, whereas on the right low (left: 1-β= 0.584; right: 1-β =0.119). Mean 
left HVs of ARMS-T were significantly larger compared to FE (t=2,25, p=0.027), wheras 
the right HV’s did not differ between these groups (t=0,70, p=0,488). Mean HVs of 
ARMS-T and ARMS-NT did not differ significantly (left t=0.33, p=0.744; right t=0.046, 
p=0.964). Mean HVs of ARMS-T also did not differ compared to HC (left t=1.288, 
p=0.202; right t=0.560, p=0.577).  
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4. DISCUSSION  
The current cross-sectional MRI study compared manually traced HVs between ARMS, 
FEP and HC adjusted for sex and whole brain volumes. Whereas the right HVs did not 
differ between the groups, we found a significant difference in left HVs between ARMS, 
FEP and HC (P=0.035), with a left HV reduction of 6.9% in FEP compared to ARMS, 
and a left HVs reduction of 4.5% in FEP compared to HC. We also showed that mean 
left HVs of ARMS subjects with later transition to psychosis (ARMS-T) were significantly 
larger compared to FE, whereas the right HV’s did not differ between these groups 
(t=0,70, p=0,488). Contrary to our expectation, we were not able to demonstrate left or 
right HV differences between ARMS and HC, nor within the ARMS group (ARMS-T vs. 
ARMS-NT).  
 
Our findings in patients are consistent with previous neuroimaging reports from the same 
sample (Borgwardt et al, 2007a, 2008; Haller et al., 2009) and similar to other ARMS 
samples (Velakoulis et al, 2006; Meisenzahl et al, 2008), as well as longitudinal MRI 
studies using voxel-based morphometry methods, where progressive volumetric 
reductions in hippocampal and parahippocampal regions were found in those ARMS 
subjects that made a transition to psychosis (Pantelis et al, 2003). Furthermore, also the 
finding that non-converters (ARMS-NT) compared to converters (ARMS-T) did not differ 
in left or right HVs is well in line with previous VBM studies of ARMS (Borgwardt et al, 
2007a; Meisenzahl et al, 2008, Pantelis et al 2003). Both converters and non-converters 
showed no difference in HV compared to healthy controls. This finding also replicates a 
previous ROI-study in a larger ARMS sample (Velakoulis et al, 2006).  
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Finally our finding of a left laterality of hippocampus abnormality is in line with some 
previous studies (Velakoulis et al, 1999, 2006), but not all (Hurlemann et al. 2008). We 
believe that there are several reasons for the inconsistent results. Previous studies 
which found an early left sided pathology usually have a younger cohort, and a more 
phenomenologically defined ascertainment strategy (Velakoulis et al, 1999, 2006), 
whereas studies with a bilateral HV reduction used different ascertainment strategies 
including older and potentially more progressed ARMS subjects with cognitive 
impairment, related to the biological substrate. 
The hippocampus is a region of high plasticity which depends on various genetic and 
environmental influences (Cruther and Collins, 1982; Knable et al, 2004) including illness 
stage and treatment (Berger et al, 2003). The hippocampal plasticity may also explain 
why, left HV in ARMS was slightly bigger than in HC (albeit not significantly) and 
significantly bigger than in FEP. The latter is in line with an earlier study by Phillips et al 
(2002) and might precede the onset of psychosis. The underlying substrate for such a 
‘swelling’ prior to the actual conversion to psychosis could be an increased apoptotic 
activity involving a transient controlled inflammatory response while removing apoptotic 
cells, or cell parts (axons and dendrites) (Berger et al, 2003; Lieberman et al, 2007). If 
true, this may imply that new benign neuroprotective treatment strategies may be 
especially effective in this late phase of prodrome and be able to modulate underlying 
neurobiological processes and potentially delay or even prevent the onset of psychosis 
(Berger et al, 2007) 
Our study may not be fully comparable to other structural MRI studies because different 
research groups have used slightly different ways of defining their high risk (Fusar-Poli P 
et al, 2008; Yung et al, 2008) and first episode psychosis (McGorry et al, 2004; 
Schimmelmann et al 2005) cohorts, used different ascertainment strategies, different 
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anatomic boundaries of the hippocampus (with or without amygdala) as well as applied 
different techniques to measure HV (i.e. manual vs. automated methods). MRI scanner 
technology has also changed rapidly over the past decades, and different studies may 
therefore hardly be comparable (e.g. different slice thickness in older studies). The 
methods and extent of detailed information how ROIs were defined varies across 
studies, again suggesting that the information may not be easily comparable. 
Furthermore, there is a large difference in potential confounding factors across studies 
(i.e. sex, duration of illness, age of onset, medication, drug use, parental and socio-
economic status), which makes a direct comparison across studies difficult. Another 
likely reason for the inconclusiveness of previous studies is that pathological changes of 
brain structure in schizophrenia might not be limited to one or a few clearly defined brain 
regions. There is considerable evidence that the pathological changes in patients with 
schizophrenia may be at the level of spatially distributed networks that include multiple, 
densely interconnected cortical and subcortical regions (Weinberger et al, 1992; Wright 
et al, 2000, Witthaus H. et al, 2008) highlighting that schizophrenia may be rather a 
whole brain disorder and interpretation of changes in one single region can potentially be 
misleading.  
Finally, it is unlikely that these findings are specific to schizophrenia (Geuze et al, 2005). 
Smaller HV have also been reported in other neurological (Alzheimer’s disease: Teipel 
et al, 2003; Parkinson’s disease: Brueck et al 2004; Epilepsy: Marsh et al 2001; 
Huntington’s disease: Rosas et al 2003, medical cardiac arrest: Fujioka et al 2000; 
Cushing disease: Starkman et al 1999; amnesia: Isaacs et al 2003; Herpes simplex: 
Colchester et al 2001) and psychiatric (Major Depression: Bremner et al 2000; Bipolar 
disorder: Bearden et al, 2008) disorders.  
A major limitation of our study is the relatively small sample size with the consequence 
that we may be unable to detect small group differences because of limited statistical 
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power. For analysis 1, post hoc test applying the Bonferroni assumption for multiple 
testing was not able to uphold the significance. Since the power of the group effects is 
low, a correction for multiple testing is probably disproportionately conservative and the 
likelihood of a type II error (‘false negative’) applying such post hoc tests is quite high. 
Furthermore, the cross-sectional nature of the data limits interpretation as HV 
differences may be an epiphenomenom of another underlying disease pathology such 
as a dysregulation in the HPA axis (Phillips et al, 2006). Finally, our FEP and ARMS 
sample was not completely drug naive, bearing the risk that drug effects might have 
masked some of the volumetric abnormalities (Lieberman et al, 2005). However, 89% of 
the ARMS subjects were naive to these medications and the few ARMS subjects who 
received antipsychotic medications were treated only for behavioral control with very low 
doses and over a very short time period (< 3 weeks). Therefore, if a medication effect 
was present, it was mainly relevant for the FEP group and more likely to protect the 
hippocampus than the opposite (Liebermann et al, 2005).  
In conclusion, our study provides further evidence that macrostructural hippocampal 
abnormalities probably occur in the context of the first psychotic breakdown. With regard 
to the hippocampus, it suggests a biphasic course of events which encompasses a 
primary swelling proximal to psychosis onset and a secondary volumetric diminution, 
supporting a rather neuroprogressive model of psychotic disorders. Future studies 
investigating hippocampal abnormalities should use longitudinal approaches from ARMS 
onwards with larger sample sizes and neuroendocrinological and cognitive 
measurement to shed light on the underlying neuropathology of hippocampus 
abnormalities in emerging psychotic disorders.  
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Table 1 
 
Transition criteria  
At least one of the following symptoms:  
 
i.  Suspiciousness (BPRS ≥5): subject says others are maliciously talking about  
 him/her, have negative intentions or may induce harm (incidents more than once  
 a week OR partly delusional conviction).  
 
ii. Unusual thought content (BPRS ≥5): full delusion(s) with some preoccupation OR  
 some areas of functioning disrupted (not only ideas of reference/persecution,  
 unusual beliefs or bizarre ideas without fixed delusional conviction)  
 
iii.  Hallucinations (BPRS ≥4): occasional hallucinations OR visual illusions >2/week 
 or with functional impairment (not only hearing of own name, non-verbal acoustic  
 or formless visual hallucinations/illusions).  
 
iv.  Conceptual disorganization (BPRS ≥5): speech difficult to understand due to 
  circumstantiality, tangentiality, neologisms, blockings or topic shifts (most of the 
  time OR three to five instances of incoherent phrases).  
 
Symptoms at least several times a week.  
Change in mental state lasting >1 week.  
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Table 2 Demographic and clinical characteristics 
 ARMS FEP HC p 
 (n=37) (n=23) (n=22)  
Age at baseline (mean 
years, SD) 
24.7 (5.6) 26.78 (6.5) 23.0 (4.3) ns1)3)  
Sex (male) 22 (59%) 17 (74%) 13 (59%) ns4) 
Handedness (mixed or left)  4 (17%) 5 (22%) 6 (29%)  ns4) 
Educational level     <0.054) 
<9 yrs 11 (30%) 12 (52%) 2 (9%)  
9-11 yrs 14 (38%) 8 (34%) 7 (32%)  
12-13 yrs 8 (22%) 1 (4%) 10 (46%)  
>13 yrs 4 (11%) 2 (9%) 3 (14%)  
Individuals with a first 
degree relative with 
schizophrenia 
5 (14%) 4 (17%)  ns4) 
Mean BPRS global score at 
intake (SD) 
39.2 (9.0) 52.7 (13.6) na <0.0013) 
Mean SANS at intake (SD) 8.0 (5.0) 10.0 (5.3) na ns3) 
Patients with antipsychotics  4 (11%) 9 (39%) na <0.055) 
Duration of Illness (mean 
monthes, SD) 
44.1 (46.0) 54.9 (74.1) na ns3) 
1) not significant  
2) not applicable 
3) ANOVA  
4) χ2-test  
5) Fisher’s exact test  
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Table 3  Demographic and clinical characteristics 
 
ARMS-T        ARMS-NT p 
 
(n=16) (n=21) 
 
Age at baseline (mean 
years, SD) 
26.44 (6.5) 23.4 (6.0) ns1) 
Sex (male) 11 (69%) 11 (52%) ns2)  
Handedness (mixed or 
left)  
3 (19%) 1 (5%) ns2) 
Educational level    ns3) 
<9 yrs 4 (25%) 7 (35%)  
9-11 yrs 6 (38%) 8 (39%)  
12-13 yrs 5 (31%) 3 (13%)  
>13 yrs 1 (6%) 3 (13%)  
Individuals with a first 
degree relative with 
schizophrenia 
3 (19%) 3 (14%) ns3) 
Mean BPRS global score 
at intake (SD) 
41.9 (10.6) 37.2 (7.1) ns1) 
Mean SANS summary 
score at intake (SD) 
9.5 (5.4)  6.8 (4.4)  ns1) 
Patients with 
antipsychotics  
2 (13%) 2 (9%) ns2) 
Duration of Illness (mean 
monthes, SD) 
42.6 (39.5) 43.2 (53.7) ns1) 
1) Student’s t-tests 
2)
 Fisher’s exact test  
3)
 χ2-test 
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Table 4  Whole brain and hippocampal volumes (raw and adjusted for whole brain volume) 
 
 Group Whole Brain volume 
  
Hippocampal 
volume left 
  
Hippocampal 
volume right 
  
Adjusted 
Hippocampal 
volume left 
Adjusted 
Hippocampal 
volume right 
  mm3 (SD) (mm3) (SD) (SD) (SD) (mm3) (SD) (mm3)   (SD) 
ARMS  
(n=37) 1286747.8 113673.6 2915.8 311.8 3178.1 361.6 2980.1 374.6 3242.8   374.6 
- ARMS-T 
(n=16) 1293439.1 103026.3 2956.3 251.4 3194.3 215.5 3003.7 311.8 3246.1   306.6 
- ARMS-NT 
(n=21) 1281649.6 123430.6 2885.0 353.9 3165.8 447.4 2962.2 422.9 3240.3   426.6 
FEP 
(n=23) 1307844.2 115519.9 2761.0 231.9 3139.6 249.4 2775.9 288.5 3159.7   344.4 
HC 
(n=22) 1307372.5 108978.1 2897.2 221.5 3196.9 235.8 2907.8 231.8 3210.7   271.0 
 
